Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02626364
Title Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arog Pharmaceuticals, Inc.
Indications

glioblastoma

gliosarcoma

Therapies

Crenolanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.